GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Incannex Healthcare Ltd (STU:IQI) » Definitions » Other Operating Expense

Incannex Healthcare (STU:IQI) Other Operating Expense : €-3.62 Mil (TTM As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Incannex Healthcare Other Operating Expense?

Incannex Healthcare's Other Operating Expense for the three months ended in Mar. 2024 was €-1.22 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was €-3.62 Mil.

Incannex Healthcare's quarterly Other Operating Expense declined from Sep. 2023 (€0.00 Mil) to Dec. 2023 (€-2.50 Mil) but then increased from Dec. 2023 (€-2.50 Mil) to Mar. 2024 (€-1.22 Mil).

Incannex Healthcare's annual Other Operating Expense declined from Jun. 2020 (€1.29 Mil) to Jun. 2021 (€-0.02 Mil) and declined from Jun. 2021 (€-0.02 Mil) to Jun. 2022 (€-0.51 Mil).

Incannex Healthcare Other Operating Expense Historical Data

The historical data trend for Incannex Healthcare's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Incannex Healthcare Other Operating Expense Chart

Incannex Healthcare Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 0.48 1.29 -0.02 -0.51

Incannex Healthcare Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.08 0.09 - -2.50 -1.22

Incannex Healthcare Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-3.62 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Incannex Healthcare Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Incannex Healthcare's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Incannex Healthcare (STU:IQI) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Incannex Healthcare Ltd (STU:IQI) » Definitions » Other Operating Expense
Comparable Companies
PNXP CYTH BGXX DRRX RMTI QLI CPIX INIS SHWZ TXMD ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ VTRS SZSE:000538 NBIX
Traded in Other Exchanges
IXHL:USA
Address
8 Century Circuit Norwest, Suite 105, Sydney, NSW, AUS, 3000
Website
https://www.incannex.com.au
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products.